Trial Profile
Effective and safe examination of teneligliptin for the type 2 diabetes with dialysis patient
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Oct 2021
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Oct 2021 Status changed from recruiting to completed.
- 02 Oct 2013 New trial record